Clinical implications of prostaglandin and thrombo...[N Engl J Med. 1988]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

1: N Engl J Med. 1988 Sep 15;319(11):689-98.Links

Clinical implications of prostaglandin and thromboxane A2 formation (1).

Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.

PMID: 3045550 [PubMed - indexed for MEDLINE]

The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease.
Petidis K, Douma S, Doumas M, Basagiannis I, Vogiatzis K, Zamboulis C. BMC Cardiovasc Disord. 2008 May 27; 8:11. Epub 2008 May 27.

[BMC Cardiovasc Disord. 2008]
ReviewPhysical (in)activity and endothelium-derived constricting factors: overlooked adaptations.
Thijssen DH, Rongen GA, Smits P, Hopman MT. J Physiol. 2008 Jan 15; 586(2):319-24. Epub 2007 Oct 25.

[J Physiol. 2008]
Homologous desensitization of signalling by the alpha (alpha) isoform of the human thromboxane A2 receptor: a specific role for nitric oxide signalling.
Kelley-Hickie LP, O'Keeffe MB, Reid HM, Kinsella BT. Biochim Biophys Acta. 2007 Jun; 1773(6):970-89. Epub 2007 Mar 28.

[Biochim Biophys Acta. 2007]
» See all...

Your browsing activity is empty.

Activity recording is turned off.

Display Show